Veradigm Inc.
MDRX · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Revenue | $1 | $1 | $2 | $2 |
| % Growth | 1.8% | -61.6% | -8% | – |
| Cost of Goods Sold | $0 | $0 | $1 | $1 |
| Gross Profit | $0 | $0 | $1 | $1 |
| % Margin | 52.5% | 44.7% | 37.6% | 35.2% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $0 | $0 | $1 | $1 |
| Operating Income | -$0 | $0 | -$0 | -$0 |
| % Margin | -4.6% | 13.1% | -3.8% | -6.1% |
| Other Income/Exp. Net | -$0 | $0 | -$0 | -$0 |
| Pre-Tax Income | -$0 | $0 | -$0 | -$0 |
| Tax Expense | -$0 | $0 | -$0 | -$0 |
| Net Income | -$0 | $0 | $1 | -$0 |
| % Margin | -14.7% | 23.3% | 46.6% | -11.2% |
| EPS | -0.67 | 1.03 | 4.37 | -1.1 |
| % Growth | -165% | -76.4% | 497.3% | – |
| EPS Diluted | -0.67 | 1.01 | 4.37 | -1.1 |
| Weighted Avg Shares Out | 0 | 130 | 0 | 166 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 9.9% | 42.2% | 7.3% | 0.7% |